Immune parameters in patients with anxiety or depression during psychotherapy

Journal of Affective Disorders

Volumn 81, Issue 3, 2004, Pages 201-209

  Atanackovic, D ^a,b   Kroger H ^c   Serke, S ^d   Deter, H C ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Anxiety disorder; CD4 + CD8 + ratio; Depression; Psychoneuroimmunology; Psychotherapy

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LUCIGENIN; REACTIVE OXYGEN METABOLITE;

ADULT; ANXIETY DISORDER; ARTICLE; CELL COMPOSITION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEPRESSION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE STATUS; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE SUBPOPULATION; MALE; MEASUREMENT; PHAGOCYTE; PILOT STUDY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; SUPPRESSOR CELL;

ADULT; ANXIETY DISORDERS; CASE-CONTROL STUDIES; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PSYCHOTHERAPY;

EID: 4344598541     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(03)00165-4     Document Type: Article

References (55)

1. Arriaga F., Paiva T., Matos-Pires A., Cavaglia F., Lara E., Bastos L. The sleep of non-depressed patients with panic disorder: a comparison with normal controls. Acta Psychiatr. Scand. 93:1996;191-194
2. Atanackovic D., Brunner-Weinzierl M.C., Kröger H., Serke S., Deter H.C. Acute psychological stress simultaneously alters hormone levels, recruitment of lymphocyte subsets, and production of reactive oxygen species. Immunol. Invest. 31:2002;73-91
3. Bartlett J.A., Demetrikopoulos M.K., Schleifer S.J., Keller S.E. Phagocytosis and killing of Staphylococcus aureus: effects of stress and depression in children. Clin. Diagn. Lab. Immunol. 4:1997;362-366
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 4:1961;561-571
5. Benca R.M., Obermeyer W.H., Thisted R.A., Gillin J.C. Sleep and psychiatric disorders. Arch. Gen. Psychiatry. 49:1992;651-668
6. Brambilla F., Bellodi L., Perna G., Battaglia M., Sciuto G., Diaferia G., Petraglia F., Panerai A., Sacerdote P. Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology. 26:1992;12-22
7. Caldwell C.L., Irwin M., Lohr J. Reduced natural killer cell cytotoxicity in depression but not in schizophrenia. Biol. Psychiatry. 30:1991;1131-1138
8. Darko D.F., Lucas A.H., Gillin J.C., Risch S.C., Golshan S., Hamburger R.N., Silverman M.B., Janowsky D.S. Cellular immunity and the hypothalamic-pituitary axis in major affective disorder: a preliminary study. Psychiatry Res. 25:1988;1-9
9. Deitch E.A., Xu D., McIntyre Bridges R. Opioids modulate human neutrophil and lymphocyte function: thermal injury alters plasma β-endorphin levels. Surgery. 104:1988;41-48
10. Eisen J.N., Irwin J., Quay J., Livnat S. The effect of antidepressants on immune function. Biol. Psychiatry. 26:1989;805-817
11. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature. 408:2000;239-247
12. Hosker H.S.R., Kelly C., Corris P.A. Assessment of phagocytic function using chemiluminescence. Blood Rev. 3:1989;88-93
13. Irwin M., Gillin J.C. Impaired natural killer cell activity among depressed patients. Psychiatry Res. 20:1987;181-182
14. Irwin M., Daniels M., Bloom E.T., Smith T.L., Weiner H. Life events, depressive symptoms, and immune function. Am. J. Psychiatry. 144:1987;437-441
15. Irwin M. Depression and immune function. Stress Med. 4:1988;95-103
16. Irwin M., Lacher U., Caldwell C. Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol. Med. 22:1992;1045-1050
17. Irwin M. Immune correlates of depression. Dantzer X.,, et al. Cytokines, Stress, and Depression. 1999;1-24 Kluwer Academic/Plenum, New York
18. Katon W., Sullivan M.D. Depression and chronic medical illness. J. Clin. Psychiatry. 51:1990;3-11
19. Koh K.B., Lee B.K. Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosom. Med. 60:1998;479-483
20. Kronfol Z., Silva J., Greden J., Dembinski S., Gardner R., Carrol B. Impaired lymphocyte function in depressive illness. Life Sci. 33:1983;241-247
21. Landmann R., Schaub B., Link S., Wacker H.R. Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy. Biol. Psychiatry. 41:1997;675-681
22. Leonard B.E. Changes in the immune system in depression and dementia: causal or co-incidental effects. Int. J. Dev. Neurosci. 19:2001;305-312
23. Maes M., Bosmans E., Suy E., Minner B., Raus J. Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process. Br. J. Psychiatry. 155:1989;793-798
24. Maes M., Lambrechts J., Bosmans E., Jacobs J., Suy E., Vandervorst C., De Jonckheere C., Minner B., Raus J. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Neuropsychobiology. 25:1992;94-98
25. Maes M., Stevens M., DeClerck L., Bridts C., Peeters D., Schotte C., Cosyns P. Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio. Acta Psychiatr. Scand. 86:1992;423-431
26. Maes M., Stevens W., DeClerck L., Peeters D., Bridts C., Schotte C., Meltzer H., Scharpé S., Cosyns P. Neutrophil chemotaxis, phagocytosis, and superoxide release in depressive illness. Biol. Psychiatry. 31:1992;1220-1224
27. Maes M., Stevens W., Peeters D., DeClerck L., Scharpe S., Bridts C., Schotte C., Cosyns P. A study on the blunted natural killer cell activity in severely depressed patients. Life Sci. 50:1992;505-513
28. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 19:1995;11-38
29. Maes M., Vandoolaeghe E., Ranjan R., Bosmans E., Bergmans R., Desnyder R. Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J. Affect. Disord. 36:1995;29-36
30. Maini M.K., Gilson R.J.C., Chavda N., Gill S., Fakoya A., Ross E.J., Phillips A.N., Weller I.V.D. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin. Med. 72:1996;27-31
31. Marazziti D., Ambrogi F., Vanacore R., Mignani V., Savino M., Palego L., Cassano G.B., Akiskal S. Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology. 26:1992;23-26
32. McCafferty A.C., Cree I.A., McMurdo M.E.T. The influence of age and sex on phagocyte chemiluminescence. J. Biolumin. Chemilumin. 10:1995;41-48
33. Miller R.A. The aging immune system: primer and prospectus. Science. 273:1996;70-74
34. Mohl P.C., Huang L., Bowden C., Fischbach M., Vogtsberger K., Talal N. Natural killer cell activity in major depression. Am. J. Psychiatry. 144:1987;1619
35. Moldofsky H. Central nervous system and peripheral immune functions and the sleep-wake system. J. Psychiatry Neurosci. 19:1994;368-374
36. Müller N., Hopfschuster E., Ackenheil M., Mempel W., Eckstein R. Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 17:1993;713-730
37. Murris Espin M., Pinelli E., Pipy B., Leophonte P., Didier A. Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production. Allergy. 50:1995;334-339
38. Murphy J.M., Olivier D.C., Sobol A.M., Monson R.R., Leighton A.H. Diagnosis and outcome: depression and anxiety in a general population. Psychol. Med. 16:1986;117-126
39. Rapaport M.H. Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers. Biol. Psychiatry. 43:1998;458-463
40. Schepank H., Tress W. Die stationäre Psychotherapie und ihr Rahmen. 1988;Springer, Heidelberg
41. Schleifer S.J., Keller S.E., Meyerson A.T., Raskin M.J., Davis K.L., Stein M. Lymphocyte function in major depressive disorder. Arch. Gen. Psychiatry. 41:1984;484-486
42. Schleifer S.J., Keller S.E., Siris S.G., Davis K.L., Stein M. Depression and immunity. Lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients, and patients hospitalized for herniorrhaphy. Arch. Gen. Psychiatry. 42:1985;129-133
43. Schleifer S.J., Keller S.E., Bond R.N., Cohen J., Stein M. Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch. Gen. Psychiatry. 46:1989;81-87
44. Schleifer S.J., Keller S.E., Bartlett J.A. Panic disorder and immunity: few effects on circulating lymphocytes, mitogen response, and NK cell activity. Brain Behav. Immun. 16:2002;698-705
45. + natural killer cells and related cytokines in major depression. Clin. Immunol. Immunopathol. 78:1996;83-85
46. Sluzewska A. Indicators of immune activation in depressed patients. Adv. Exp. Med. Biol. 461:1999;59-73
47. Smith R.S. The macrophage theory of depression. Med. Hypotheses. 35:1991;298-306
48. Sopori M.L., Kozak W. Immunomodulatory effects of cigarette smoke. J. Neuroimmunol. 83:1998;148-156
49. Spielberger C.D., Gorusch R.L., Lushene R.E. STAI, Manual for the State-Trait-Anxiety-Inventory. 1970;Consulting Psychologist Press, Palo Alto
50. Stein M.B., Uhde T.W. Panic disorder and major depression. A tale of two syndromes. Psychiatr. Clin. North Am. 11:1988;441-461
51. Surman O.S., Williams J., Sheehan D.V., Strom T.B., Jones K.J., Coleman J. Immunological response to stress in agarophobia and panic attacks. Biol. Psychiatry. 21:1986;768-774
52. Tondo L., Pani P.P., Pellegrini-Bettoli R., Milia G., Manconi P.E. T-lymphocytes in depressive disorder. Med. Sci. Res. 16:1988;867-868
53. Wozniak A., McLennan G., Betts W.H., Murphy G.A., Scicchitano R. Activation of human neutrophils by substance P: effect on FMLP-stimulated oxidative and arachidonic acid metabolism and on antibody-dependent cell-mediated cytotoxicity. Immunology. 68:1989;359-364
54. Xiao L., Eneroth P. Tricyclic antidepressants inhibit human natural killer cells. Toxicol. Appl. Pharmacol. 137:1996;157-162
55. Zavala F. Benzodiazepines, anxiety and immunity. Pharmacol. Ther. 75:1997;199-216